Results 11 to 20 of about 869,412 (319)

Understanding cost-effectiveness [PDF]

Clinical Microbiology and Infection, 2010
Healthcare delivery in the USA and abroad has changed dramatically over the last several decades. Along with the growth in diagnostic and therapeutic interventions, the costs of healthcare have escalated out of proportion relative to other aspects of the economy.
Zilberberg, M.D., Shorr, A.F.
openaire   +2 more sources

Cost‐effectiveness of asthma clinic approach in the management of chronic asthma in Australia

Australian and New Zealand Journal of Public Health, 2013
Objectives: To compare cost‐effectiveness of an asthma clinic that would provide education, promotion of self‐monitoring of symptoms, regular review of treatment by a medical practitioner and a written asthma action plan to current practice in Australia.
Vittal Mogasale, Theo Vos
doaj   +1 more source

Review of the evidence for the potential impact and feasibility of substituting saturated fat in the New Zealand diet

Australian and New Zealand Journal of Public Health, 2013
Objective: To estimate the potential impact on cardiovascular health of modifying dietary intake of saturated fat across the New Zealand population, and whether this would be appropriate and feasible.
Rachel H. Foster, Nick Wilson
doaj   +1 more source

Potential impact of a modest reduction in salt intake on blood pressure, cardiovascular disease burden and premature mortality: a modelling study

Open Heart, 2019
Objective To assess the potential impact of reduction in salt intake on the burden of cardiovascular disease (CVD) and premature mortality in Cameroon.Methods Using a multicohort proportional multistate life table model with Markov process, we modelled ...
J Lennert Veerman, Leopold Ndemnge Aminde, Linda J Cobiac   +2 more
doaj   +1 more source

Effectiveness of cost-effectiveness [PDF]

British Journal of Psychiatry, 2012
In their economic modelling, Barret & Byford[1][1] postulate that the intervention group will have a reoffending rate of 3% v . 5% in the non-intervention group, but give no evidence of this being the correct figure or even the justification for this being a reasonable estimate.
openaire   +2 more sources

Cost-effectiveness analysis of adding durvalumab to chemotherapy as first-line treatment for advanced biliary tract cancer based on the TOPAZ-1 trial

Cost Effectiveness and Resource Allocation, 2023
Background Durvalumab plus gemcitabine and cisplatin has a significant clinical benefit for advanced biliary tract cancer (BTC). However, the high price of durvalumab warrants an exploration of the economics.
Qiuling Zhao, Ruixiang Xie, Wanfu Zhong, Wenbin Liu, Ting Chen, Xiuliang Qiu, Lin Yang   +6 more
doaj   +1 more source

Essential emergency and critical care as a health system response to critical illness and the COVID19 pandemic: what does it cost?

Cost Effectiveness and Resource Allocation, 2023
Essential Emergency and Critical Care (EECC) is a novel approach to the care of critically ill patients, focusing on first-tier, effective, low-cost, life-saving care and designed to be feasible even in low-resourced and low-staffed settings.
Lorna Guinness, Angela Kairu, August Kuwawenaruwa, Karima Khalid, Khamis Awadh, Vincent Were, Edwine Barasa, Hiral Shah, Peter Baker, Carl Otto Schell, Tim Baker   +10 more
doaj   +1 more source

Cost-Effectiveness Analysis [PDF]

Journal of Nuclear Medicine, 2009
Before any attempt to address the issues implied in the article by Mohan and Miles ( [1][1] ) in this issue of The Journal of Nuclear Medicine , a brief and deliberately simplistic review of methodologic basics may facilitate understanding by nonexpert readers of that article ( [1][1] ). Cost-
openaire   +2 more sources

Likelihood of residential aged care use in later life: a simple approach to estimation with international comparison

Australian and New Zealand Journal of Public Health, 2015
Objectives: In New Zealand (NZ), place of death among decedents aged 65+ years has been reported as residential aged care (RAC, 38%), acute hospital (34%) or elsewhere (28%). However, lifetime risk of use of RAC (or nursing homes) is unknown.
Joanna B. Broad, Toni Ashton, Merryn Gott, Heather McLeod, Peter B. Davis, Martin J. Connolly   +5 more
doaj   +1 more source

Healthcare costs for hospitalized COVID-19 patients in a Japanese university hospital: a cross-sectional study

Cost Effectiveness and Resource Allocation, 2023
Background A health-economic evaluation related to COVID-19 is urgently needed to allocate healthcare resources efficiently; however, relevant medical cost data in Japan concerning COVID-19 are scarce.
Shunsuke Uno, Rei Goto, Kimiko Honda, Machiko Tokuda, Hirofumi Kamata, Shotaro Chubachi, Ryo Yamamoto, Yukio Sato, Koichiro Homma, Sho Uchida, Ho Namkoong, Yoshifumi Uwamino, Junichi Sasaki, Koichi Fukunaga, Naoki Hasegawa   +14 more
doaj   +1 more source